Get access

Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles

Authors

  • Sue D. Xiang,

    Corresponding author
    1. Department of Immunology, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria 3004, Australia
    • Department of Immunology, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria 3004, Australia
    Search for more papers by this author
  • Cordelia Selomulya,

    1. Department of Chemical Engineering, Monash University, Clayton, Victoria 3800, Australia
    Search for more papers by this author
  • Jenny Ho,

    1. Department of Chemical Engineering, Monash University, Clayton, Victoria 3800, Australia
    Search for more papers by this author
  • Vasso Apostolopoulos,

    1. Immunology and Cancer Vaccine Laboratory, Burnet Institute, Melbourne, Victoria 3004, Australia
    Search for more papers by this author
  • Magdalena Plebanski

    1. Department of Immunology, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria 3004, Australia
    Search for more papers by this author

Abstract

Vaccination offers a cost-effective approach to the control of endemic infectious and a less invasive treatment modality against cancers. Since the discovery that injecting DNA encoding antigens (expressed in vivo) results in the induction of CD8 T cells as well as antibody mediated immunity, researchers have tried to develop methods to consistently enhance this immunity to disease protective levels in humans. Adsorption, coformulation, or encapsulation with particles has been found to both stabilize DNA formulations, through preventing rapid degradation, and provide vaccine adjuvanting effects, largely due to effective uptake of particulate materials by antigen presenting cells. Recently, it has been shown that nanoparticles, as opposed to microparticles, based DNA vaccine carriers are preferentially taken up by dendritic cells resulting in the induction of maximal levels of combined humoral and cellular immunity. WIREs Nanomed Nanobiotechnol 2010 2 205–218

For further resources related to this article, please visit the WIREs website

Get access to the full text of this article

Ancillary